Intriguing evidence suggests Alzheimer’s disease may have a link to infectious diseases or a microbial mechanism. Could this be the missing link to lead to a cure for Alzheimer’s disease?
To advance research that could shed light and provide hope to the more than 5.7 million Americans and 47 million people worldwide living with the disease, the IDSA Foundation established the Alzheimer’s Research Grant, now known as the Microbial Pathogenesis in Alzheimer’s Disease Grant, in 2018 to foster further investigation. These grants support research that suggests an infectious agent or microbial community is correlated to Alzheimer’s disease and promotes novel research in the field of microbial triggers for Alzheimer’s disease.
Due to overwhelming interest in this opportunity, the 2023 funding cycle deadline application has been extended to December 23, 2022. Click this link to begin your application.
To read full press release about the Microbial Pathogenesis in Alzheimer’s Disease Grant, click here.
FREQUENTLY ASKED QUESTIONS
- Both members and non-members of IDSA are encouraged to apply. This includes established investigators and academic and health professionals in all disciplines and health-related professions.
- PhDs and MDs are encouraged to apply.
- Interdisciplinary research is encouraged, including collaborations between experts in Alzheimer’s research and infectious diseases.
- Clinical and basic scientists are encouraged to apply.
- International applicants and non-U.S. citizens are eligible to apply.
- February 2023: Grant cycle begins
- August 2023: Interim reports due
- February 2024: Grant cycle ends
The application period for the 2023 Microbial Pathogenesis in Alzheimer’s Disease Grant is now open.
For more information:
Contact IDSA Foundation Program Manager Amari Pearson-Fields, PhD, MPH at email@example.com
about the funders
Alzheimer’s Germ Quest (ALZgerm.org) is a public benefit corporation with the mission of accelerating and deepening investigations into possible microbial causes of Alzheimer’s disease.
The Benter Foundation was founded in 2007 to help communities and individuals thrive. Since then, the Foundation has invested to advance a more livable Pittsburgh, emphasizing the city’s urban core. Reaching beyond Pittsburgh, the Foundation supports peace-building efforts and innovators who create new knowledge to tackle large scale issues. Path-breaking solutions are needed in health challenges like Alzheimer’s disease and opioid abuse. The Benter Foundation believes that the battle against Alzheimer’s will be won through innovative scientific research.
In 2021 we awarded more than $1.7 million in grant funds to researchers investigating possible links between infectious diseases and the causation of Alzheimer’s disease. Chosen from among 78 exceptional applications, 11 awardees received grants ranging from $30,000 for fellows or early-career investigators to obtain preliminary data to $250,000 for established investigators who have already developed initial research. The grant funds will be used to initiate or expand their research.